A detailed history of Adar1 Capital Management, LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 320,727 shares of APLT stock, worth $2.83 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
320,727
Previous 456,588 29.76%
Holding current value
$2.83 Million
Previous $3.1 Billion 51.76%
% of portfolio
0.28%
Previous 0.7%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$4.04 - $6.37 $548,878 - $865,434
-135,861 Reduced 29.76%
320,727 $1.5 Billion
Q1 2024

May 15, 2024

BUY
$2.25 - $7.4 $1.03 Million - $3.38 Million
456,588 New
456,588 $3.1 Billion

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $423M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.